Effects of interleukin-6 (IL-6) on cycling status and clonogenic maturation of human fetal (cord blood) and adult hematopoietic progenitors were compared. Adult marrow cells were incubated for various lengths of time with various concentrations of IL-6, in a serum-free system, after which tritiated thymidine suicide studies were performed. After incubation of 2 to 5 x 10' cells/mL for 4 hours in 5.0 ng IL-G/mL. increased thymidine suicide rates were observed for multipotent progenitors (CFU-Mix), granulocyte-macrophage progenitors (CFU-GM). and erythroid burst-forming units (BFU-E). Similar incubations of fetal cells in IL-6 resulted in similar increases in tritiated thymidine suicide rates. In other studies, IL-6 used alone did not support colony formation from adult progenitors. Multipotent hematopoietic progenitors obtained from the marrow of adults are generally residing in G0,6-* but most such progenitors obtained from the umbilical cord blood or liver of fetal subjects a r e actively cycling.'.'' It is not clear whether the increased cycling rate of fetal progenitors is due to endogenous stimulation by IL-6. Indeed, whether IL-6 has any effect on human fetal hematopoietic progenitors is not known. Thus, the present studies were performed to compare the effect of IL-6 on human progenitors on fetal and adult origin.
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However, it did support colony formation from fetal CFUMix ( P < .05), CFU-GM ( P < .001). and BFU-E ( P < .05). In cultures of adult progenitors, IL-6 acted synergistically with IL-3 to support CFU-Mix colony formation ( P < .001), but synergistic actions on CFU-GM and BFU-E were not seen. In contrast, IL-6 acted synergistically with IL-3 and with GM-CSF to support colony formation by fetal CFUMix, CFU-GM. and BFU-E. Thus, IL-6 appears to have a wider spectrum of action on fetal progenitors from cord blood than on adult progenitors; including not only the induction of cycling, but also the support of clonogenic maturation of CFU-Mix, CFU-GM, and BFU-E. 0 1990 by The American Society of Hematology.
(Genetics Institute, Cambridge, MA), had a specific activity of 3.5 x lo5 U/mg, with a purity by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of greater than 99.3%.
Purified recombinant human IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF) (kindly provided by Dr Steven Gillis, Immunex Corporation, Seattle, WA) both had specific activities >4 x IO' U/mg. Purified recombinant human G-CSF (Immunex) had a specific activity in excess of lo7 U/mg. Purified recombinant human IL-6 (R&D Systems, Minneapolis, MN) was produced in Escherichia coli and purified to homogeneity (295% by SDS-PAGE) by sequential chromatography. Anti-IL-6 neutralizing antibody (R&D Systems) was raised in goats immunized with purified recombinant human IL-6. At a concentration of 10 pg/mL this antibody neutralized 299% of the biologic activity of 7.5 ng/mL of human recombinant IL-6, but did not crossreact with either GM-CSF or G-CSF as assessed with Western blot or enzyme linked immunosorbent assay (ELISA).
Adult or fetal cells (1 to 2 x 106/mL) were incubated in serum-free conditions (MEM, HyClone, Logan, UT) containing various concentrations of IL-6 (0, 0.05,0.5, or 5.0 ng/mL), or as a control, 5.0 ng/mL of IL-6 that had been preincubated for 1 hour, at 2OoC, with 10 pg of anti-IL-6 antibody. The length of incubation of cells with IL-6 was varied from 1 to 24 hours. In other studies, adult and fetal cells were incubated with either a control (a MEM), IL-6 (5.0 ng/mL), IL-3 (5.0 ng/mL), GM-CSF (5.0 ng/mL), Epo (5 U/mL), G-CSF (5.0 ng/mL), or the combination of IL-6, IL-3, and G-CSF (all at 5.0 ng/mL). After the incubations, tritiated thymidine of high specific activity (80 Ci/mmol/L, New England Nuclear, North Billerica, MA) was added to some of the tubes, and cold thymidine to duplicate tubes, for an additional 20-minute incubation, with agitation every 5 minute^.^.'^ Clonogenic cultures. After the above mentioned 20-minute incubations, cells were washed twice and cultured (2 to 10 x IO' cells/mL) in the presence of the combination of IL-3 (1 ng/mL), GM-CSF (1 ng/mL), G-CSF (1 ng/mL), and Epo (2 U/mL). Quadruplicate 1-mL culture dishes contained a MEM (HyClone), 5 x mol/L 8-mercaptoethanol (Eastman Chemical Co, Rochester, NY), 30% fetal calf serum (HyClone), 1% bovine serum albumin (Sigma Chemicals, St Louis MO), and 1.1% methylcellulose (Sigma). After 14 days of culture, colonies were categorized in situ as GM colonies if they contained no red elements and were composed of greater than 50 cells. They were categorized as BFU-E colonies if they were composed exclusively of red tightly clustered, multi-centered aggregates, and were categorized as Mix-colonies if they contained red tightly clustered aggregates plus nonred loosely arranged cells. In other studies, we sought to determine the effect of IL-6 (0, 0.1, 1 .O, and 10.0 ng/mL), alone or in combination with IL-3 (0, 0.1, and 1.0 ng/mL) or GM-CSF (0, 0.1, and 1.0 ng/mL), on colony formation by fetal and adult cells. In these studies, fetal and adult specimens were first depleted of mature erythrocytes, granulocytes, and T lymphocytes by a modification" of the procedures described by Sieff et al.I4.l5 In brief, light density cells (specific gravity < 1.077), not adherent to plastic, were incubated with murine anti-human T lymphocyte (Leu-1 and Leu-5b, Becton-Dickinson, Mountain View, CA), anti-monocyte (Leu-M5, Becton-Dickinson), and antiglycophorin antibodies (kindly supplied by Dr Richard Langlois, Laurence Livermore Laboratories, Livermore, CA). Then, cells to which the murine IgG had attached were removed by one of two methods: either by panning in plates coated with goat anti-mouse IgG (Zymed, San Francisco, CA) or by incubation with magnetic beads coated with goat anti-mouse IgG (Dynabeads, PLS Biochemical, Gaithersburg, MD) followed by removal of cells with a magnet.6 Cells were then cultured at a density of 2 to 5 x 103/mL, in quadruplicate culture plates, stimulated with various concentrations of IL-6 alone, IL-6 plus IL-3, or IL-6 plus GM-CSF. After 72 hours of culture, Epo (2 U/mL) was added to the plates." After 14 days of culture, colonies were scored in situ. In some studies, BFU-E colonies were lifted from culture plates and individually placed into 1 mL a MEM. After repeated aspiration and dispension through a finely drawn Pasteur pipette to disperse the cells, the numbers of cells per colony was determined using electronic cell counting (Coulter Electronics, Hialeah, FL).
RESULTS

Effect of IL-6 on cycling status of hematopoietic progenitors.
Light density marrow cells were incubated for 4 hours in serum-free media containing various concentrations of IL-6. The effect of such incubations on susceptibility of progenitors to tritiated thymidine of high specific activity is shown in Fig 1 . Marrow cells incubated with no IL-6 (control) displayed little or no tritiated thymidine-induced cell-kill. The studies on cells incubated with 0.05 ng IL-6/ mL were not different from studies on cells undergoing the control incubation. However, incubations with 0.5 ng IL-6/ mL and 5.0 ng IL-6/mL resulted in an increased sensitivity of CFU-Mix, BFU-E, and CFU-GM to tritiated thymidine.
In the next studies, adult marrow cells were incubated for various lengths of time in serum-free media containing 5 ng IL-6/mL. After the incubations, tritiated thymidine suicide studies were performed. As shown in Fig 2, 1 -hour incuba- tions with IL-6 resulted in increased sensitivity of BFU-E to tritiated thymidine, and 4-hour incubations resulted in increased sensitivity of CFU-Mix, BFU-E, and CFU-GM. After 24-hour incubations in serum-free conditions, the overall cloning efficiency was reduced to 0.9 f 0.2 colonies/ 1,000 cells plated (from 2.4 f 0.2 colonies generated/ 1,000 cells plated after 4-hour incubations) (P < .Ol), and progenitors showed little or no sensitivity to tritiated thymidine.
In other studies, adult and fetal cells were incubated for 4 hours in either IL-6, IL-3, GM-CSF, Epo, G-CSF, or the combination of IL-6, IL-3, and G-CSF. The upper panel of Fig 3 displays the effect of such incubations on adult progenitors. Incubation with IL-6 resulted in increased tritiated thymidine suicide rates of all three progenitor types. Incubation with IL-3 resulted in an increased rate of CFUMix only. No effect was observed after incubation with GM-CSF. Incubation with Epo resulted in an increased rate for BFU-E only, incubation with G-CSF resulted in an increased rate of CFU-GM only. The effect of incubating with the combination was not different than incubating with IL-6 alone.
The lower panel of Fig 3 displays the effect of these incubations on fetal progenitors. Fetal progenitors had higher preincubation thymidine suicide rates than did adult progenitors. However, as with adult progenitors, IL-6 incubations resulted in increased thymidine suicide rates of all three progenitor types. Incubation with IL-3 induced an increase in CFU-Mix only, incubation with G-CSF induced an increase in CFU-GM only, and incubation with the combination was not different than incubation with IL-6 alone.
Effect of ZL-6 on clonal maturation ofprogenitors. Fetal progenitors were cultured in various concentrations of IL-6, either alone or combined with various concentrations of IL-3 or GM-CSF. As shown in Table 1 , 1L-6 as a single agent supported the clonal development of fetal CFU-GM, BFU-E, and CFU-Mix. In addition, combining IL-6 with IL-3 resulted in more CFU-GM, BFU-E, and CFU-Mix-derived colonies than when IL-3 or IL-6 were used alone. Combining IL-6 with a sub-maximal concentration (0.1 ng/mL) of GM-CSF also resulted in increased generation of CFU-GM, BFU-E, and CFU-Mix-derived colonies over that obtained by IL-6 or GM-CSF alone.
BFU-E colonies grown in the combination of IL-6 (10.0 ng/mL) plus IL-3 (1.0 ng/mL) were composed of more individual centers than colonies grown in IL-3 alone. Figure  4 shows results of a study in which all BFU-E colonies composed of 2 10 centers were examined and then lifted from the plates for cell counting. The colonies grown in IL-3 alone were composed of 24 (range 14 to 44) individual centers/ colony, while those grown in IL-6 plus IL-3 contained 40
(range 22 to 82, P < .OS, Mann-Whitney U-test). However, the number of normoblasts recovered per colony did not differ; from 2 1 0 centered BFU-E colonies grown in IL-3 alone 14,060 f 4,850 (X SD) normoblasts were recovered, and from colonies grown in IL-6 plus IL-3 14,530 f 7,730 normoblasts were recovered. In contrast to its support of colony formation by fetal progenitors, IL-6 as a single agent failed to support clonal maturation of progenitors from adults (Table 2) . Also unlike its action on fetal progenitors, no additive effect was observed between IL-6 and IL-3 or GM-CSF in supporting CFU-GM or BFU-E colony formation. However, when combined with IL-3, IL-6 did increase the formation of CFU-Mix-derived colonies.
DISCUSSION
Hematopoietic progenitors, obtained by marrow aspiration of healthy adults, are generally residing in a nonproliferating state. Evidence supporting this assertion includes the resistance of these progenitors to cell cycle-active cytotoxic ' and Leary et ala suggest that IL-6 might be one such extracellular factor. However, whether IL-6 induces cycling of adult or fetal progenitors in vivo has not been defined. Indeed, whether IL-6 has any effect on fetal hematopoietic progenitors has not previously been reported. In the present experiments, we observed that IL-6 was capable of inducing cycling of fetal progenitors in vitro. Whether IL-6 is responsible for the rapid cycling rate of fetal progenitors in vivo, however, remains to be determined.
Although we observed a similar effect of IL-6 on the induction of cycling of adult and'fetal progenitors, substantial differences were noted on its effect on clonal maturation of adult versus fetal progenitors. Specifically, as a single agent, IL-6 supported formation of fetal CFU-GM, BFU-E, and CFU-Mix colonies, but did not support such formation from adult progenitors. This latter observation differs somewhat from that of Caracciolo et al, 3 ' who reported that IL-6, We also noted that IL-6 acted synergistically with IL-3 and GM-CSF to support formation of fetal CFU-GM, BFU-E, and CFU-Mix colonies, while its only observed synergistic action on adult progenitors was with IL-3, to support CFU-Mix colonies.
IL-6 also resulted in a morphologic difference in fetal BFU-E colonies. Specifically, colonies stimulated by the combination of IL-6 and IL-3 were composed of more individual centers than those developing after stimulation with IL-3 alone. Eaves and Eaves33 noted that multicentered BFU-E colonies were more resistant to thymidine of high specific activity, and appeared later in culture, than BFU-E colonies with few centers. Thus, the combination of IL-6 plus IL-3 may have supported colony production from a more primitive population of BFU-E. Alternatively, perhaps the increased number of centers was a result of the cycleinducing properties of IL-6 on the first generation of BFU-E daughter cells, which migrate from each other before development of the individual subclones that characterize BFU-E colonies.34 An effect of IL-6 on colony morphology was also noted by Bot et who observed that if IL-6 was added to cultures stimulated with M-CSF, the resulting CFU-GM colonies were larger than those stimulated with M-CSF alone.
Our observation of a wider spectrum of action of IL-6 on supporting clonal maturation of fetal than adult progenitors is similar to the observations of Emerson et aI2' and Valtieri et a12* on the spectrum of action of Epo. Both groups observed that, in vitro, Epo has a wider spectrum of action on fetal progenitors, supporting clonal maturation of BFU-E as well as CFU-E.
The present studies do not clarify whether the increased spectrum of action of IL-6 on clonal maturation of fetal progenitors is due to unique properties of fetal progenitors, or whether adult progenitors might also be induced to display these properties under certain conditions, such as the rapid hematopoietic expansion being experienced by the fetus.36 However, IL-6 can clearly induce cycling, and can support clonal differentiation of fetal progenitors in vitro. The role of IL-6 in fetal hematopoiesis, in vivo, remains to be defined. For personal use only. on October 23, 2017. by guest www.bloodjournal.org From
